Search research articles
Contact Us
Filters
Showing results (111-120 of 129) with videos related to
Page
of 13
Sort By:
The Journal of Infectious Diseases
|
May 1, 1983
Treatment and prophylaxis of disseminated infection due to Candida albicans in mice with liposome-encapsulated amphotericin B
G Lopez-Berestein, R Mehta, R L Hopfer, et al.
The Journal of Infectious Diseases
|
April 1, 1985
Liposomal amphotericin B for the treatment of systemic fungal infections in patients with cancer: a preliminary study
G Lopez-Berestein, V Fainstein, R Hopfer, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 15, 2001
Phase I trial of intratumoral liposome E1A gene therapy in patients with recurrent breast and head and neck cancer
G H Yoo, M C Hung, G Lopez-Berestein, et al.
Leukemia & Lymphoma
|
March 1, 1993
Disseminated visceral fusariosis treated with amphotericin B-phospholipid complex
D Engelhard, A Eldor, I Polacheck, et al.
Oncogene
|
January 7, 1998
Bcl-2 inhibits p53 nuclear import following DNA damage
A Beham, M C Marin, A Fernandez, et al.
Cancer Gene Therapy
|
March 4, 2006
Mutant Bik expression mediated by the enhanced minimal topoisomerase IIalpha promoter selectively suppressed breast tumors in an animal model
C-P Day, K-M Rau, L Qiu, et al.
The Journal of Infectious Diseases
|
July 1, 1992
Experimental Trichosporon infection in persistently granulocytopenic rabbits: implications for pathogenesis, diagnosis, and treatment of an emerging opportunistic mycosis
T J Walsh, J W Lee, G P Melcher, et al.
Oncogene
|
September 27, 2016
Targeting KRas-dependent tumour growth, circulating tumour cells and metastasis in vivo by clinically significant miR-193a-3p
E G Seviour, V Sehgal, D Mishra, et al.
Oncogene
|
August 30, 2016
Antiangiogenic and tumour inhibitory effects of downregulating tumour endothelial FABP4
U Harjes, E Bridges, K M Gharpure, et al.
Antimicrobial Agents and Chemotherapy
|
October 23, 1997
Pharmacokinetic profile of ABELCET (amphotericin B lipid complex injection): combined experience from phase I and phase II studies
A Adedoyin, J F Bernardo, C E Swenson, et al.
Page
of 13
Search research articles
Search
Showing results (111-120 of 129) with videos related to
Sort By:
Page
of 13
The Journal of Infectious Diseases
|
May 1, 1983
Treatment and prophylaxis of disseminated infection due to Candida albicans in mice with liposome-encapsulated amphotericin B
G Lopez-Berestein, R Mehta, R L Hopfer, et al.
The Journal of Infectious Diseases
|
April 1, 1985
Liposomal amphotericin B for the treatment of systemic fungal infections in patients with cancer: a preliminary study
G Lopez-Berestein, V Fainstein, R Hopfer, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 15, 2001
Phase I trial of intratumoral liposome E1A gene therapy in patients with recurrent breast and head and neck cancer
G H Yoo, M C Hung, G Lopez-Berestein, et al.
Leukemia & Lymphoma
|
March 1, 1993
Disseminated visceral fusariosis treated with amphotericin B-phospholipid complex
D Engelhard, A Eldor, I Polacheck, et al.
Oncogene
|
January 7, 1998
Bcl-2 inhibits p53 nuclear import following DNA damage
A Beham, M C Marin, A Fernandez, et al.
Cancer Gene Therapy
|
March 4, 2006
Mutant Bik expression mediated by the enhanced minimal topoisomerase IIalpha promoter selectively suppressed breast tumors in an animal model
C-P Day, K-M Rau, L Qiu, et al.
The Journal of Infectious Diseases
|
July 1, 1992
Experimental Trichosporon infection in persistently granulocytopenic rabbits: implications for pathogenesis, diagnosis, and treatment of an emerging opportunistic mycosis
T J Walsh, J W Lee, G P Melcher, et al.
Oncogene
|
September 27, 2016
Targeting KRas-dependent tumour growth, circulating tumour cells and metastasis in vivo by clinically significant miR-193a-3p
E G Seviour, V Sehgal, D Mishra, et al.
Oncogene
|
August 30, 2016
Antiangiogenic and tumour inhibitory effects of downregulating tumour endothelial FABP4
U Harjes, E Bridges, K M Gharpure, et al.
Antimicrobial Agents and Chemotherapy
|
October 23, 1997
Pharmacokinetic profile of ABELCET (amphotericin B lipid complex injection): combined experience from phase I and phase II studies
A Adedoyin, J F Bernardo, C E Swenson, et al.
Page
of 13